Employers are facing one of the fastest-rising costs in healthcare today: GLP-1 medications prescribed now account for 17% of U.S. employer pharmacy claims, in large part due to the increased demand for weight-loss medications. Beyond cost, there are additional GLP-1 challenges that employers are experiencing, including growing demand, emerging indications and adherence issues.
All this being said, it’s worth noting that more employers are facing the risks of the “GLP-1 cliff” — a sharp drop in engagement and outcomes that can occur when employees lose access to medications due to cost, coverage limits or lack of long-term support. Fortunately, employers don’t need to start from scratch. There’s already a foundation of trusted, proven strategies to turn early wins into lasting health.
